Nykredit A/S’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152K Hold
4,504
– – ﹤0.01% 1143
2026
Q2
$174K Buy
+4,504
New +$137K ﹤0.01% 1092

Other funds holding IMVT

Nykredit A/S's IMVT Position: Q3 2026 in Review

Nykredit A/S held its Immunovant (IMVT) position steady in Q3 2026 at 4,504 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Nykredit A/S first reported a position in IMVT in Q2 2026 and has held it in 2 quarters since. The position peaked at $174K in Q2 2026. 229 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Nykredit A/S held 4,504 shares of Immunovant worth $152K as of Q3 2026.
  • Nykredit A/S left its Immunovant share count unchanged in Q3 2026.
  • Immunovant made up ﹤0.01% of Nykredit A/S's portfolio in Q3 2026, its #1143 holding.
  • Nykredit A/S first reported a position in Immunovant in Q2 2026 and has held it in 2 quarters since.
  • Nykredit A/S's Immunovant position peaked at $174K in Q2 2026.
  • 229 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.